1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macroeconomic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country-level data:

4. North America Therapeutic Vaccines Market - Key Market Dynamics

4.1 Market Drivers

4.1.1 Rising Prevalence of Chronic Conditions

4.1.2 Increasing Investments and Funding for Vaccine Development

4.2 Market Restraints

4.2.1 Regulatory Challenges

4.3 Market Opportunities

4.3.1 Extending Product Pipeline

4.4 Future Trends

4.4.1 Advancements in Vaccine Technology

4.5 Impact of Drivers and Restraints:

5. Therapeutic Vaccines Market - North America Market Analysis

5.1 North America Therapeutic Vaccines Market Revenue (US$ Thousand), 2021-2031

5.2 North America Therapeutic Vaccines Market Forecast Analysis

6. North America Therapeutic Vaccines Market Analysis - by Product

6.1 Cancer Vaccine

6.1.1 Overview

6.1.2 Cancer Vaccine: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

6.2 Infectious Disease Vaccine

6.2.1 Overview

6.2.2 infectious Disease Vaccine: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

6.3 Others

6.3.1 Overview

6.3.2 Others: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

7. North America Therapeutic Vaccines Market Analysis - by Technology

7.1 Allogenic Vaccine

7.1.1 Overview

7.1.2 Allogenic Vaccine: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

7.2 Autologous Vaccine

7.2.1 Overview

7.2.2 Autologous Vaccine: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

8. North America Therapeutic Vaccines Market Analysis - by End User

8.1 Hospitals

8.1.1 Overview

8.1.2 Hospitals: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

8.2 Clinics

8.2.1 Overview

8.2.2 Clinics: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

8.3 Others

8.3.1 Overview

8.3.2 Others: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

9. North America Therapeutic Vaccines Market - Country Analysis

9.1 North America

9.1.1 North America Therapeutic Vaccines Market - Revenue and Forecast Analysis - by Country

9.1.1.1 North America Therapeutic Vaccines Market - Revenue and Forecast Analysis - by Country

9.1.1.2 United States: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

9.1.1.2.1 United States: North America Therapeutic Vaccines Market Share - by Product

9.1.1.2.2 United States: North America Therapeutic Vaccines Market Share - by Technology

9.1.1.2.3 United States: North America Therapeutic Vaccines Market Share - by End User

9.1.1.3 Canada: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

9.1.1.3.1 Canada: North America Therapeutic Vaccines Market Share - by Product

9.1.1.3.2 Canada: North America Therapeutic Vaccines Market Share - by Technology

9.1.1.3.3 Canada: North America Therapeutic Vaccines Market Share - by End User

9.1.1.4 Mexico: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

9.1.1.4.1 Mexico: North America Therapeutic Vaccines Market Share - by Product

9.1.1.4.2 Mexico: North America Therapeutic Vaccines Market Share - by Technology

9.1.1.4.3 Mexico: North America Therapeutic Vaccines Market Share - by End User

10. Therapeutic Vaccines Market - Industry Landscape

10.1 Overview

10.2 Growth Strategies in the Therapeutic Vaccines Market

10.3 Organic Growth Strategies

10.3.1 Overview

10.4 Inorganic Growth Strategies

10.4.1 Overview

11. Company Profiles

11.1 Dendreon

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 BioNTech SE

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Serum Institute of India Pvt. Ltd

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Merck & Co Inc

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Amgen Inc

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 ISA Pharmaceuticals BV

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 INOVIO Pharmaceuticals Inc

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Transgene SA

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 THERAVECTYS SA

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 CureVac SE

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Products and Services

11.10.4 Financial Overview

11.10.5 SWOT Analysis

11.10.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary of Terms

List of Tables

Table 1. North America Therapeutic Vaccines Market Segmentation

Table 2. North America Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Table 3. North America Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Product

Table 4. North America Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Technology

Table 5. North America Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by End User

Table 6. North America Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Country

Table 7. United States: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Product

Table 8. United States: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Technology

Table 9. United States: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User

Table 10. Canada: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Product

Table 11. Canada: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Technology

Table 12. Canada: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User

Table 13. Mexico: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Product

Table 14. Mexico: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Technology

Table 15. Mexico: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User

Table 16. Recent Organic Growth Strategies in the Therapeutic Vaccines Market

Table 17. Recent Inorganic Growth Strategies in the Therapeutic Vaccines Market

Table 18. Glossary of Terms, Therapeutic Vaccines Market

List of Figures

Figure 1. North America Therapeutic Vaccines Market Segmentation - Country

Figure 2. North America Therapeutic Vaccines Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. North America Therapeutic Vaccines Market Revenue (US$ Thousand), 2021-2031

Figure 5. North America Therapeutic Vaccines Market Share (%) - by Product (2024 and 2031)

Figure 6. Cancer Vaccine: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 7. infectious Disease Vaccine: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 8. Others: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 9. North America Therapeutic Vaccines Market Share (%) - by Technology (2024 and 2031)

Figure 10. Allogenic Vaccine: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 11. Autologous Vaccine: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 12. North America Therapeutic Vaccines Market Share (%) - by End User (2024 and 2031)

Figure 13. Hospitals: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 14. Clinics: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 15. Others: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 16. North America Therapeutic Vaccines Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 17. United States: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)

Figure 18. Canada: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)

Figure 19. Mexico: North America Therapeutic Vaccines Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)

Figure 20. Growth Strategies in the Therapeutic Vaccines Market